Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare imaging savings

This article was originally published in The Gray Sheet

Executive Summary

Obama administration estimates that increasing the imaging equipment utilization factor used by CMS to calculate payments would save $2.5 billion over five years and $5.9 billion over 10 years in a "mid-session" 1review of the president's budget released last week. In June, as part of a plan to help pay for health reform, the administration floated the idea of changing the assumed equipment use rate from the current 50% to 95% of the time that imaging facilities are open, but did not quote specific savings figures (2"The Gray Sheet" June 22, 2009). Equipment manufacturers and radiologists have railed against the proposal, asserting that it would lead to significant underpayment for advanced imaging and harm rural clinics disproportionately. The mid-session review also shaves $10 million off the projected 10-year savings from implementation of a prior authorization requirement for Medicare-covered imaging scans - another proposal in Obama's health reform reserve fund (3"The Gray Sheet" March 2, 2009)

You may also be interested in...



White House Again Looks To Imaging Cuts To Help Raise Health Reform Funds

For the second time this year, medical imaging made it on to President Obama's list of targeted Medicare cuts that could help pay for comprehensive health reform

Obama Budget Seeks Prior Authorization For Medicare Imaging

President Obama's budget proposal for fiscal year 2010 includes a plan for Medicare to contract with private third parties to pre-review and approve imaging payments on a scan-by-scan basis

Metsera Launches As New Obesity Contender Flush With $290m

Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture. 

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT027851

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel